Related Experiment Videos
A conceptual framework for evaluating impairments in myasthenia gravis
Carolina Barnett1, Vera Bril2, Moira Kapral3
1Division of Neurology - Department of Medicine, University of Toronto and University Health Network, Toronto, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Plos One
|May 22, 2014
Summary
Myasthenia gravis severity involves both impairment level and fatigability, which impacts muscle weakness and symptom fluctuations. Understanding these factors is crucial for accurate assessment and developing better measurement tools for this neuromuscular disease.
Area of Science:
- Neurology
- Clinical Research
- Qualitative Studies
Background:
- Myasthenia gravis causes muscle weakness and fatigability affecting ocular, bulbar, and limb muscles.
- Accurate assessment requires measures reflecting all impairments and their activity-related variations.
- A qualitative study explored patient experiences to develop a conceptual framework for disease severity.
Purpose of the Study:
- To explore patient experiences with myasthenia gravis impairments and fatigability.
- To develop a conceptual framework for impairment-based disease severity in myasthenia gravis.
- To inform the development of new impairment measures for myasthenia gravis.
Main Methods:
- Semi-structured interviews were conducted with 20 patients across the disease spectrum.
- Transcripts were analyzed using inductive content analysis with line-by-line open coding.
- Themes were generated from the coded data to build the conceptual framework.
Main Results:
- Two primary themes emerged: impairment severity and fatigability.
- Impairments were categorized by body region: ocular, bulbar, and axial/limbs.
- Fatigability affects the whole body and specific impairments, leading to symptom fluctuations, a concern for accurate clinical assessment.
Conclusions:
- A conceptual framework highlighting severity and fatigability is essential for understanding myasthenia gravis.
- This framework can guide the creation of improved impairment measures for myasthenia gravis.
- Accurate assessment must account for symptom fluctuations due to fatigability.